ReviewOphthalmology and therapy2026
Optimizing the Ocular Surface Before, During, and After Glaucoma Surgery: A Narrative Review.
Review in Ophthalmology and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This narrative review synthesizes the published literature on ocular surface disease (OSD) and glaucoma filtration surgery to develop practical, evidence-informed clinical and surgical recommendations for optimizing ocular surface management before, during, and after surgery. The reviewed studies examine how OSD affects ocular inflammation and wound healing, how chronic preservative-containing topical therapy affects bleb survival, and how reducing cumulative preservative load benefits ocular surface health. In patients with glaucoma, chronic use of preservative-containing topical medications can aggravate OSD, with approximately 50% of patients receiving topical intraocular pressure-lowering therapy reporting symptoms of OSD. OSD-related inflammation and tissue changes may adversely affect wound healing and compromise the success of glaucoma filtration surgery. OSD in patients likely to require filtration surgery should be actively identified and treated throughout the preoperative, intraoperative, and postoperative stages. Practical steps include screening for OSD, reducing exposure to preservative-containing medications, optimizing the ocular surface preoperatively, and minimizing conjunctival inflammation perioperatively. These strategies can be readily adopted into clinical practice and may help optimize conditions for bleb survival, although direct evidence demonstrating improved bleb survival is limited.
Indexed as
Identifiers
42762288What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.